BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 21671547)

  • 21. When it comes to aspirin, men and women are not equal: aspirin acts differently in women.
    Sofer D
    Am J Nurs; 2005 Jun; 105(6):20. PubMed ID: 15930857
    [No Abstract]   [Full Text] [Related]  

  • 22. Antiplatelet drugs in cardiovascular prevention: coronary events and stroke: primary prevention.
    Prescrire Int; 2000 Jun; 9(47):89-90. PubMed ID: 11010752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aspirin for Primary Prevention.
    Richman IB; Owens DK
    Med Clin North Am; 2017 Jul; 101(4):713-724. PubMed ID: 28577622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Who should be taking aspirin?
    Harv Heart Lett; 2002 Apr; 12(8):3-5. PubMed ID: 11959516
    [No Abstract]   [Full Text] [Related]  

  • 25. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.
    Hennekens CH; Schneider WR
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):95-107. PubMed ID: 18095910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aspirin increases mortality in diabetic patients without cardiovascular disease: a Swedish record linkage study.
    Welin L; Wilhelmsen L; Björnberg A; Odén A
    Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1143-9. PubMed ID: 19672841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ethical considerations in relation to aspirin prophylaxis.
    Morgan G
    Qual Prim Care; 2008; 16(6):433-40. PubMed ID: 19094419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose comparisons of clopidogrel and aspirin in acute coronary syndromes.
    ; Mehta SR; Bassand JP; Chrolavicius S; Diaz R; Eikelboom JW; Fox KA; Granger CB; Jolly S; Joyner CD; Rupprecht HJ; Widimsky P; Afzal R; Pogue J; Yusuf S
    N Engl J Med; 2010 Sep; 363(10):930-42. PubMed ID: 20818903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bleeding risk with aspirin must be balanced against benefit.
    Harv Heart Lett; 2012 Aug; 22(12):8. PubMed ID: 23025025
    [No Abstract]   [Full Text] [Related]  

  • 31. A health impact assessment of increased aspirin use in Wales.
    Williams WR
    Public Health; 2006 May; 120(5):480; author reply 481. PubMed ID: 16549078
    [No Abstract]   [Full Text] [Related]  

  • 32. Aspirin for primary prevention: yes or no?
    Selak V; Elley CR; Wells S; Rodgers A; Sharpe N
    J Prim Health Care; 2010 Jun; 2(2):92-9. PubMed ID: 20690297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-dose aspirin for primary prevention of cardiovascular disease.
    Bredie SJ; Wollersheim H; Verheugt FW; Thien T
    Semin Vasc Med; 2003 May; 3(2):177-84. PubMed ID: 15199480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aspirin for the prevention of cardiovascular morbidity.
    Sanchez-Ross M; Waller AH; Maher J; Klapholz M; Haider B; Kaluski E
    Minerva Med; 2010 Aug; 101(4):205-14. PubMed ID: 21030934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aspirin for the primary prevention of cardiovascular events: recommendations and rationale.
    U.S. Preventive Services Task Force
    Am Fam Physician; 2002 May; 65(10):2107-10. PubMed ID: 12046780
    [No Abstract]   [Full Text] [Related]  

  • 36. Aspirin for the primary prevention of cardiovascular events.
    Colwell JA
    Drugs Today (Barc); 2006 Jul; 42(7):467-79. PubMed ID: 16894401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aspirin for prevention of myocardial infarction.
    Mirvis DM
    J Tenn Med Assoc; 1995 Oct; 88(10):392-4. PubMed ID: 7475013
    [No Abstract]   [Full Text] [Related]  

  • 38. Cardiology patient page: Aspirin.
    Paikin JS; Eikelboom JW
    Circulation; 2012 Mar; 125(10):e439-42. PubMed ID: 22412097
    [No Abstract]   [Full Text] [Related]  

  • 39. [Antiplatelet drugs and gastrointestinal bleeding: numquam periclum sine periclo vincitur].
    Rossini R; Lucà MG; Scuri P; Invernizzi P; Strazzabosco M; Gavazzi A
    Ital Heart J Suppl; 2005 Oct; 6(10):621-6. PubMed ID: 16273749
    [No Abstract]   [Full Text] [Related]  

  • 40. Myocardial infarction and gastro-intestinal bleeding risks associated with aspirin use among elderly individuals with type 2 diabetes.
    Sirois C; Moisan J; Poirier P; Grégoire JP
    Ann Med; 2014 Aug; 46(5):335-40. PubMed ID: 24785356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.